Stem cell company Athersys Inc. (Nasdaq: ATHX) of Cleveland said it is publishing a study that demonstrates the regenerative benefit of its MultiStem therapy after spinal cord injuries.
Athersys publishes study on benefits of its MultiStem therapy after spinal cord injury
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.